Targeting fibrin in COVID-19

IF 122.7 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Nature Reviews. Drug Discovery Pub Date : 2024-09-27 DOI:10.1038/d41573-024-00159-4

Sarah Crunkhorn

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

以 COVID-19 中的纤维蛋白为目标

发现世界上最好的科学和医学 | Nature.com

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.

期刊最新文献

FDA approves L-amino acid decarboxylase deficiency gene therapy. Benchmarking recruitment rates for phase III trials Antimalarial drug hits cardiac fibrosis JAK inhibition combats adverse skin reaction Lundbeck pays US$2.6 billion for Longboard and its lead epilepsy drug